Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery

NCT02535351 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped low enrolment

Conditions

Clear-cell Metastatic Renal Cell Carcinoma

Interventions

DRUG: sunitinib or pazopanib
PROCEDURE: Cytoreductive nephrectomy

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano